Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia

Clinical trial NCT03109093 · COMPLETED

Trial details

NCT number: NCT03109093
Sponsor: Goethe University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

ALL, Recurrent, Adult

Start date: 2017-03-15
Primary completion: 2021-08-15
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.